Key result
An increase of 1 point in DAPT score and 5 points in PRECISE-DAPT score were independently associated with a 51% (OR 1.51) and 34% (OR 1.34) increased risk of triple-vessel disease in patients with ACS.
Why the study?
Do DAPT score and PRECISE-DAPT score correlate with the extent of coronary stenosis in patients with acute coronary syndrome?
Observational (n=359)
No
Do DAPT score and PRECISE-DAPT score correlate with the extent of coronary stenosis in patients with acute coronary syndrome?
Odds Ratio: 1.51 (95% CI 1.19–1.91)
p-value: p=0.001
Both the DAPT and PRECISE-DAPT scores independently correlate with the severity of coronary stenosis in ACS patients, suggesting these bleeding and ischemia risk stratification tools also reflect anatomical disease burden.
Dual antiplatelet therapy (DAPT) score and PRECISE-DAPT score were recommended for decision making of optimal DAPT in discriminating the risk of thrombosis and bleeding. But the relationships between 2 scoring tools with the extent of coronary stenosis have not been established.We retrospectively enrolled 359 patients of acute coronary syndrome (ACS) who received percutaneous coronary intervention. Both DAPT score and PRECISE-DAPT score were calculated, and patients were divided by their recommended cut-offs. Gensini score and triple-vessel disease (3-VD) were chosen to evaluate the severity of coronary stenosis.Overall, 54.9% and 10.0% of the patients had higher DAPT score (≥2) or PRECISE-DAPT score (≥25). Patients with higher DAPT score had increased stent counts, total length of stents, Gensini score, and proportion of 3-VD, but decreased minimum diameter of stent. But these differences were not found in PRECISE-DAPT subgroups. When divided into quartiles of both scoring systems, the highest Gensini score and proportions of 3-VD were found in the fourth quartile of both DAPT score and PRECISE-DAPT score. Moreover, both DAPT score and PRECISE-DAPT score were independent risk factors of Gensini score after adjustment (P < .001 and P = .047). Furthermore, an increase of 1 point of DAPT score and 5 points of PRECISE-DAPT score resulted by 51% (odds ratios [OR]: 1.51, 95% confidence interval [CI]:1.19-1.91, P = .001) and 34% (OR: 1.34, 95% CI: 1.11-1.62, P = .003) increase in risk of 3-VD after adjustment.Both DAPT score and PRECISE-DAPT score were independently associated with the degree of coronary stenosis in patients with ACS.
No takes yet. Share an insight, caveat, or question.
Long et al. (2018) conducted an observational in Acute coronary syndrome (n=359). DAPT score and PRECISE-DAPT score vs. Lower scores was evaluated on Risk of triple-vessel disease (3-VD) per 1-point increase in DAPT score (OR 1.51, 95% CI 1.19-1.91, p=0.001). An increase of 1 point in DAPT score and 5 points in PRECISE-DAPT score were independently associated with a 51% (OR 1.51) and 34% (OR 1.34) increased risk of triple-vessel disease in patients with ACS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: